NESYX
Price
$63.19
Change
-$0.07 (-0.11%)
Updated
Jul 13 closing price
Net Assets
1.19B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

NESYX vs VSTSX

NESYX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
NESYX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NESYX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. NESYX (1.19B). VSTSX pays higher dividends than NESYX: VSTSX (1.07) vs NESYX (0.16). NESYX was incepted earlier than VSTSX: NESYX (32 years) vs VSTSX (10 years). NESYX (0.81) is less costly to investors than VSTSX (0.01). NESYX is a more actively managed with annual turnover of: 38.00 vs. VSTSX (3.00). NESYX has a lower initial minimum investment than VSTSX: NESYX (100000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. NESYX (1.95). VSTSX return over 5 years is better than : 66.56 vs. NESYX (15.05).
NESYXVSTSXNESYX / VSTSX
Total Expense Ratio0.810.018,100%
Annual Report Gross Expense Ratio0.810.018,100%
Fund Existence32 years10 years-
Gain YTD-3.01811.205-27%
Front LoadN/AN/A-
Min. Initial Investment10000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.19B2.3T0%
Annual Yield % from dividends0.161.0715%
Returns for 1 year1.9521.489%
Returns for 3 years32.3967.0648%
Returns for 5 years15.0566.5623%
Returns for 10 years95.35239.5340%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I